Important notice about stem cell research and COVID-19
In March, laboratory-based research at Harvard was put on hold, maintaining only the most critical functions to safeguard materials that are essential to our mission of finding cures and better treatments for human disease. In May, the university announced its research laboratory re-entry plan, and has been preparing for re-entry in fidelity with federal, state, local and university policy and requirements. Visit the Harvard University coronavirus website for university-wide information, and the ISSCR coronavirus page for stem-cell community resources.
Our mission is to find cures for human diseases.
Harvard Stem Cell Institute (HSCI) scientists are working together across Harvard schools, centers, and teaching hospitals, harnessing the power of stem cells to change medicine for the better.
HSCI scientists identify gut-brain connection in ALS
In mice with a common ALS genetic mutation, changing the gut microbiome using antibiotics or fecal transplants could prevent or improve disease symptoms